PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Advancing Nasal Protection: Healthcare Innovations Beyond COVID-19

The Evolution of Nasal Protection Solutions The global scientific community continues to advance research on COVID-19 and its long-term effects, commonly referred to as “long COVID.” While the pathogenicity of COVID-19 has weakened due to viral mutations, the importance of infection prevention remains paramount. Repeated infections elevate the risk of long COVID, underscoring the need for sustained vigilance.

Beyond COVID-19, seasonal influenza remains a recurring public health challenge, leading to unpredictable pandemics and posing heightened risks for pregnant women, infants, the elderly, and individuals with chronic illnesses. These vulnerable populations are particularly susceptible to respiratory infections, making preventive measures a continued priority.

Given that nasal passages process thousands of litres of air daily, they act as the first line of defence against airborne pathogens. As a result, their high susceptibility to infections from influenza viruses, coronaviruses, rhinoviruses, and airborne allergens makes effective protective measures essential.

While face masks remain the gold standard for respiratory protection, discomfort and compliance issues have led to growing interest in nasal spray-based protection. Often referred to as “liquid masks,” these sprays do not replace masks but instead provide an additional protective layer.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026